This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
AVEO Pharmaceuticals Future Growth
Future criteria checks 5/6
Key information
123.0%
Earnings growth rate
122.8%
EPS growth rate
| Biotechs earnings growth | 23.7% |
| Revenue growth rate | 36.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
AVEO Oncology shares jumped on acqusition by LG Chem for $15.00 per share in cash
Oct 18Here's Why AVEO Pharmaceuticals (NASDAQ:AVEO) Can Manage Its Debt Despite Losing Money
Oct 04
A Current Assessment On AVEO Pharmaceuticals
Aug 15Rock star Growth Puts AVEO Pharmaceuticals (NASDAQ:AVEO) In A Position To Use Debt
Jun 21AVEO Pharmaceuticals Is Primed For A Breakout
May 24Here's What Analysts Are Forecasting For AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) After Its Annual Results
Mar 17AVEO Pharmaceuticals: Finally Ready To Reboot
Mar 09AVEO Pharmaceuticals (NASDAQ:AVEO) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Mar 03AVEO Pharmaceuticals (NASDAQ:AVEO) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 23AVEO Pharmaceuticals: Sticking To The Plan
Oct 29AVEO Pharmaceuticals: Making Its Mark In Cancer Treatment
Jul 24AVEO Oncology: Time To Be Patient
Jun 07AVEO outlines 2021 outlook; initiates Phase 1 trial for cancer complication
Jan 07AVEO Oncology: Managing A Position Ahead Of Tivozanib's PDUFA
Dec 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 214 | 48 | N/A | N/A | 1 |
| 12/31/2023 | 162 | 12 | N/A | N/A | 1 |
| 12/31/2022 | 110 | -24 | N/A | N/A | 1 |
| 9/30/2022 | 94 | -29 | -23 | -23 | N/A |
| 6/30/2022 | 79 | -36 | -31 | -31 | N/A |
| 3/31/2022 | 61 | -41 | -47 | -47 | N/A |
| 12/31/2021 | 42 | -53 | -57 | -57 | N/A |
| 9/30/2021 | 26 | -58 | -58 | -58 | N/A |
| 6/30/2021 | 14 | -56 | -56 | -56 | N/A |
| 3/31/2021 | 7 | -49 | -45 | -45 | N/A |
| 12/31/2020 | 6 | -36 | -38 | -38 | N/A |
| 9/30/2020 | 6 | -29 | -33 | -32 | N/A |
| 6/30/2020 | 28 | -4 | -8 | -8 | N/A |
| 3/31/2020 | 28 | 0 | -6 | -6 | N/A |
| 12/31/2019 | 29 | 9 | -3 | -3 | N/A |
| 9/30/2019 | 30 | 36 | -2 | -2 | N/A |
| 6/30/2019 | 6 | -3 | -24 | -24 | N/A |
| 3/31/2019 | 6 | 4 | -27 | -27 | N/A |
| 12/31/2018 | 5 | -5 | -25 | -25 | N/A |
| 9/30/2018 | 4 | -24 | -22 | -22 | N/A |
| 6/30/2018 | 6 | -28 | -22 | -22 | N/A |
| 3/31/2018 | 6 | -65 | -20 | -20 | N/A |
| 12/31/2017 | 8 | -65 | -19 | -19 | N/A |
| 9/30/2017 | 8 | -74 | -23 | -23 | N/A |
| 6/30/2017 | 4 | -53 | -29 | -29 | N/A |
| 3/31/2017 | 4 | -28 | -26 | -26 | N/A |
| 12/31/2016 | 3 | -27 | -31 | -31 | N/A |
| 9/30/2016 | 6 | -28 | -24 | -24 | N/A |
| 6/30/2016 | 20 | -15 | N/A | -6 | N/A |
| 3/31/2016 | 20 | -12 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVEO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: AVEO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AVEO is expected to become profitable in the next 3 years.
Revenue vs Market: AVEO's revenue (36.2% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: AVEO's revenue (36.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AVEO's Return on Equity is forecast to be high in 3 years time